DentalGoodNews|Dental Credible Information Platform


国家医保局:全国参保人数逾13亿,基金累计结存近4万亿元

 
Issuing time:2025-07-18 14:14Author:编辑部
*图源:国家医疗保障局官网
*图源:国家医疗保障局官网

好的牙·讯|国家医疗保障局近日发布《2024年全国医疗保障事业发展统计公报》。公报显示,截至2024年底,全国基本医疗保险参保约13.27亿人,参保率巩固在95%。

2024年,全国基本医保(含生育保险)基金总收入34913.37亿元,总支出29764.03亿元,统筹基金当期结存4639.17亿元,累计结存38628.52亿元。

*图源:国家医疗保障局官网
*图源:国家医疗保障局官网

其中,职工医保参保37948.34万人,同比增长2.3%。职工医保基金收入23732.47亿元,同比增长3.5%;支出19102.54亿元,同比增长7.6%。

*图源:国家医疗保障局官网
*图源:国家医疗保障局官网

城乡居民基本医保参保94713.73万人,居民医保基金收入11180.91亿元,支出10661.49亿元。

职工医保待遇享受达53.08亿人次,次均住院费用11707元,住院费用目录内基金支付比例为84.8%。居民医保待遇享受30.35亿人次,次均住院费用7408.08元,支付比例为68.6%。三级、二级、一级及以下医疗机构间费用及支付比例存在梯度差异。

医保改革持续深化。2024年版国家医保药品目录收载药品3159种,年内新纳入91种。按病种付费覆盖范围显著扩大,出院人次占比超90%。国家层面累计组织10批药品集采覆盖435种药品,5批高值医用耗材集采覆盖7大类产品。

医保基金监管方面,2024年全国医保系统共追回医保基金275亿元,其中通过经办协议处理挽回基金损失233.63亿元,拒付或追回资金涉及定点医药机构28.99万家。查实欺诈骗保机构2008家,联合公安机关侦办医保案件3018起,抓获犯罪嫌疑人10741名。通过智能监管子系统挽回医保基金损失31亿元。

*图源:国家医疗保障局官网
*图源:国家医疗保障局官网

医保基金持续赋能经济社会发展。国家医保局成立以来基金累计支出16.48万亿元,年均增速11%。2018至2024年医保谈判新增药品销售额超5400亿元。职工医保个人账户共济改革深化,2024年家庭共济使用资金512亿元。

Member Trending Reads

Member Trending Reads

副标题

Full - mouth denture restoration is included in medical insurance. The industry concentration is at a low level, and there is huge room for integration. Are you ready to embrace new opportunities?
Regulation: Not to restrict growth, but to weed out bad apples & protect good ones—let quality firms shine in fair competition!
"Cooling Momentum, Unwavering Resilience" – The Dental Industry Is Marching Toward "Quality Restoration"!
California's New Bill Sets Clear Boundaries for Dentists' Decision-Making Authority: How to Balance Clinical Autonomy Amid the Capitalization Wave?
Mental Health: A Casualty of the Healthcare System — Who Foots the Bill for Practitioners’ Physical & Mental Well-Being?
National Dental Expansion Rebounds | 940 Net New (Sep)—What’s the Future Potential?
Standardized Implants → Millimeter-Level Orthognathic Bone Resection: Robots Reshaping Dental Surgery’s Execution Logic & Tech Boundaries!
【GOODNEWS】 Content for industry reference only (based on public info & professional judgment); not for decision-making. Readers bear full responsibility for their own judgment and risks. Copyright © This Platform. Unauthorized reproduction & commercial use prohibited. Errata, contributions & cooperation: Contact customer service via WeChat:HDSW_001
✉️
Subscribe to Our
Newsletter
We curate important stories and exclusive insights, delivered straight to your inbox.
In-depth analysis · Exclusive content · Fast-moving news
1
Contact Us


Cooperation & Contact: haodeya@dongxizixun.com
Industry Updates

Industry Updates

副标题